# Anticoagulant Treatments and Percutaneous Coronary Angioplasty

> **NCT00669149** · PHASE4 · TERMINATED · sponsor: **Centre Hospitalier de PAU** · enrollment: 99 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** clopidogrel + aspirin
- **DRUG:** heparin + clopidogrel + aspirin
- **DRUG:** enoxaparin + clopidogrel + aspirin
- **DRUG:** bivalirudin + clopidogrel + aspirin

## Key facts

- **NCT ID:** NCT00669149
- **Lead sponsor:** Centre Hospitalier de PAU
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-06
- **Primary completion:** 2013-08-03
- **Final completion:** 2013-08-03
- **Target enrollment:** 99 (ACTUAL)
- **Why stopped:** recruitment difficulties
- **Last updated:** 2019-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00669149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00669149, "Anticoagulant Treatments and Percutaneous Coronary Angioplasty". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00669149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*